Extended lymph-node dissection in gastric cancer: Standard, selective or unnecessary procedure?

Hepato-Gastroenterology

Volumn 47, Issue 33, 2000, Pages 904-906

  Roukos, Dimitrios ^a,b   Paraschou, Paraskevi ^a  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b NONE   (Greece)

Author keywords

Extensive (D2 D3); Gastric cancer; Limited (D1) lymph node dissection; Morbidity; Mortality; Prognosis; Survival

Indexed keywords

ARTICLE; CANCER SURVIVAL; LYMPHADENECTOMY; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL TIME;

HEPATECTOMY; HUMANS; LYMPH NODE EXCISION; RANDOMIZED CONTROLLED TRIALS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0034047156     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. 1 Fugii M, Sasaki J, Nakashima T: State of the art in the treatment of gastric cancer; from the 71st Japanese Gastric Cancer Congress. Gastric Cancer 1999; 2:151-157.
2. 2 Marujama K, Okabayashi K, Kinoshita T: Progress in gastric cancer surgery in Japan and its limits of radicality. World J Surg 1987; 11:418-425.
3. 3 Nishi M, Omori Y, Miwa K (Eds.): Japanese classification of gastric carcinoma. Japanese Research Society for Gastric Cancer (JRSGC). 1st English Edition. Tokyo: Kanehara & Co., 1995.
4. 4 Sobin LH, Wittekind CH (Eds.): TNM classification of malignant tumors. International Union Against Cancer (UICC). 5th Edition. New York: John Wiley & Sons, 1997.
5. 5 Roukos DH: Current status in gastric cancer management and future perspectives. Cancer Treat Rev 2000. (Review) (In press)
6. 6 Siewert JR, Boettcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer. Ten-year results of the German Gastric cancer Study. Ann Surg 1998; 228:449-461.
7. 7 Bonnenkamp JJ, Hermans J, Sasako M, van de Velde CJH, et al: Extended lymph-node dissection for gastric cancer. N Engl J Med 1999; 340:908-914.
8. 8 Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resection for gastric cancer: long-term results of the MRC randomised surgical trial. Surgical co-operation group. Br J Cancer 1999; 79:1522-1530.
9. 9 Sackett DL, Rosenberg WMC, Gray JAM, Haynes RB, Richardson WS: Evidence based medicine: what it is and what it isn't. BMJ 1996; 312:71-74.
10. 10 Brennan MF: Lymph-node dissection for gastric cancer. New Engl J Med 1999; 340:956-958. (Editorial)
11. 11 Roukos DH, Lorenz M, Encke A: Evidence of survival benefit of extended lymphadenectomy in Western gastric cancer patients based on a new concept. A prospective long-term follow-up study. Surgery 1998; 123:573-578.
12. 12 Degiuli M, Sasako M, Soldati T, et al: Results of the Italian Gastric Cancer Study Group prospective multicenter surgical trial on D2-gastrectomy for gastric cancer. In: Kim JP, Min JS, Mok YJ (Eds.). Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. Bologna (Italy): Monduzzi Editore, 1999; pp. 155-161.
13. 13 Bunt AMG Hermans J, Smit VTHBM, van de Velde CJH, Fleuren GJ, Bruijn JA: Surgical/pathologic-stage migration confounds comparison of gastric cancer survival rates between Japan and Western countries. J Clin Oncol 1995; 13:19-25.
14. 14 Bonnenkamp JJ, Hermans J, Sasako M, van de Velde CJH: Quality control of lymph node dissection in the Dutch randomized trial of D1 and D2 lymph node dissection for gastric cancer. Gastric Cancer 1998; 1:152-159.
15. 15 Wagner PK, Ramaswamy A, Ruschoff J, Schmitz-Moormann P, Rothmund M: Lymph node counts in the upper abdomen: Anatomical basis for lymphadenectomy in gastric cancer. Br J Surg 1991; 78:825-827.
16. 16 Roukos DH: Current advances and changes in treatment strategy may improve survival and quality of life in patients with potentially curable gastric cancer. Ann Surg Oncol 1999; 6:46-56.
17. 17 Roukos DH: Therapeutic value of D2-resection in gastric cancer evaluated with a new concept. UICC Consensus Conference. In: Kim JP, Min JS, Mok YJ (Eds.). Proceedings of the 3rd International Gastric Cancer Congress, Seoul 1999. Bologna (Italy): Monduzzi Editore, 1999; pp. 29-33.